melatonin has been researched along with osteoprotegerin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaku, T; Koyama, H; Lau, KH; Nakade, O; Takada, Y | 1 |
| Anton, C; Garcia, P; Histing, T; Holstein, JH; Klein, M; Matthys, R; Menger, MD; Pohlemann, T; Scheuer, C | 1 |
| Ostrowska, Z; Oświęcimska, J; Szapska, B; Wołkowska-Pokrywa, K; Ziora, K | 1 |
| Cutando, A; de Diego, RG; de Vicente, J; Fernández, MH; Ferrera, MJ; López-Valverde, A; Reiter, R | 1 |
| Geng, D; Guo, X; Hou, Z; Hu, X; Ping, Z; Shi, J; Tao, Y; Wang, L; Wang, Z; Wu, X; Xu, Y; Yang, H; Zhang, W | 1 |
| D'Amico, F; Dudakovic, A; Enderby, B; Enderby, LT; Maria, S; Samsonraj, RM; Swanson, MH; van Wijnen, AJ; Witt-Enderby, PA | 1 |
| Burnouf, T; Chang, HM; Chen, LY; Feng, SW; Huang, YK; Kao, PF; Lee, WF; Lin, CT; Renn, TY; Wang, HW | 1 |
| Aşcı, H; Özmen, Ö; Sarıtekin, E; Üreyen Kaya, B | 1 |
| Ming, J; Tian, Y | 1 |
| Abdel Aziz, O; Aboulmagd, I; Ahmed, WAEA; Ragab, R; Refahee, SM; Shabaan, AA | 1 |
1 trial(s) available for melatonin and osteoprotegerin
| Article | Year |
|---|---|
The Effect of Local Melatonin Application Following the Removal of an Impacted Mandibular Third Molar.
Topics: Adult; Anti-Inflammatory Agents; Cellulose; Edema; Female; Humans; Male; Mandible; Melatonin; Molar, Third; Osteoprotegerin; Pain, Postoperative; Prospective Studies; Tooth Extraction; Tooth, Impacted | 2023 |
9 other study(ies) available for melatonin and osteoprotegerin
| Article | Year |
|---|---|
Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
Topics: Animals; Bone Density; Bone Resorption; Carrier Proteins; Cell Line; Down-Regulation; Gene Expression; Glycoproteins; Male; Melatonin; Membrane Glycoproteins; Mice; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tibia | 2002 |
Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling.
Topics: Animals; Biomechanical Phenomena; Bone Remodeling; Bone Resorption; Collagen Type I; Dose-Response Relationship, Drug; Down-Regulation; Femoral Fractures; Fracture Healing; Melatonin; Mice; Mice, Inbred Strains; Models, Animal; Osteoclasts; Osteoprotegerin; RANK Ligand | 2012 |
Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa.
Topics: Adolescent; Anorexia Nervosa; Body Mass Index; Bone and Bones; Bone Remodeling; Child; Enzyme-Linked Immunosorbent Assay; Female; Hormones; Humans; Hydrocortisone; Melatonin; Osteoprotegerin; Peptide Hormones; Pituitary Gland; RANK Ligand; Reference Values; Thyroid Gland | 2013 |
Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease.
Topics: Administration, Topical; Adult; Aged; Diabetes Mellitus; Female; Gingiva; Humans; Male; Melatonin; Middle Aged; Osteoprotegerin; Periodontal Diseases; RANK Ligand; Saliva | 2014 |
Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
Topics: Animals; beta Catenin; Bone Regeneration; Cell Differentiation; Disease Models, Animal; Intercellular Signaling Peptides and Proteins; Male; Melatonin; Mesenchymal Stem Cells; Mice, Inbred C57BL; Osteoclasts; Osteogenesis; Osteolysis; Osteoprotegerin; RANK Ligand; Skull; Titanium; Wnt Signaling Pathway | 2017 |
Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopen
Topics: Aged; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cholecalciferol; Coculture Techniques; Double-Blind Method; Female; Glucose Transport Proteins, Facilitative; Health Status; Humans; Melatonin; Micronutrients; Middle Aged; Osteoblasts; Osteoclasts; Osteoprotegerin; Postmenopause; PPAR gamma; Quality of Life; RANK Ligand; Strontium; Vitamin K 2 | 2017 |
Prophylactic supplement with melatonin successfully suppresses the pathogenesis of periodontitis through normalizing RANKL/OPG ratio and depressing the TLR4/MyD88 signaling pathway.
Topics: Animals; Antioxidants; Male; Melatonin; Myeloid Differentiation Factor 88; Osteoprotegerin; Periodontitis; Pre-Exposure Prophylaxis; RANK Ligand; Rats; Rats, Wistar; Signal Transduction; Toll-Like Receptor 4 | 2018 |
Anti-inflammatory and antiresorptive functions of melatonin on experimentally induced periapical lesions.
Topics: Animals; Anti-Inflammatory Agents; Melatonin; Osteoclasts; Osteoprotegerin; Periapical Periodontitis; RANK Ligand; Rats; Rats, Sprague-Dawley; Tartrate-Resistant Acid Phosphatase | 2019 |
Melatonin inhibits osteoclastogenesis via RANKL/OPG suppression mediated by Rev-Erbα in osteoblasts.
Topics: Cell Differentiation; Glucose; Humans; Ligands; Melatonin; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Osteoprotegerin; RANK Ligand | 2022 |